Skip Navigation

Vaccine Safety Bibliography-August 2014

1. Pursuing new vaccine formulations for use in developing countries. Vet Rec. 2014 Jul 5;175(1):6.

2. Revised guidance on the choice of pertussis vaccines: July 2014. Wkly Epidemiol Rec. 2014 Jul 25; 89(30):337-40. Review. English, French.

3. Research into TB vaccination 'will not be hindered by lack of resources'. Vet  Rec. 2014 Jul 19;175(3):56.

4. Children remain at risk of whooping cough despite vaccination. Nurs Stand. 2014 Jul 16; 28(46):16.

5. Opel et Al. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132(6):1037-1046. Pediatrics. 2014 Jul; 134(1):193.

6. Abad R, Vázquez JA. [Polyvalent meningococcal vaccines. Within or outside our  agenda?]. An Pediatr (Barc). 2014 Jul 24. [Epub ahead of print] Spanish.

7. Altenburg AF, Kreijtz JH, de Vries RD, Song F, Fux R, Rimmelzwaan GF, Sutter G, Volz A. Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases. Viruses. 2014 Jul 17;6(7):2735-61.

8. Andrews N, McMenamin J, Durnall H, Ellis J, Lackenby A, Robertson C, von Wissmann B, Cottrell S, Smyth B, Moore C, Gunson R, Zambon M, Fleming D, Pebody R. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Euro Surveill. 2014 Jul 10;19(27).

9. Antommaria AH. Response to open peer commentaries on "an ethical analysis of mandatory influenza vaccination of health care personnel: implementing fairly and balancing benefits and burdens". Am J Bioeth. 2014 Jul;14(7):W1-4.

10. Antonella S, Domenico M, Domenico T. Health Effects of Vaccinium Myrtillus L.: Evaluation of Efficacy and Technological Strategies for Preservation of Active Ingredients. Mini Rev Med Chem. 2014 Jul 21. [Epub ahead of print].

11. Antonova E, Ambrose CS, Kern D, Block SL, Caspard H, Tunceli O. Seasonal influenza vaccination trends from 2007-2011 in privately insured children and adults in the United States. Vaccine. 2014 Jul 18. [Epub ahead of print].

12. Arya SC, Agarwal N. Comment on: evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh. Vaccine. 2014 Jul 7;32(32):4013.

13. Aspinall R, Lang PO. Vaccine responsiveness in the elderly: best practice for the clinic. Expert Rev Vaccines. 2014 Jul; 13(7):885-94.

14. Baldi A. Surface Modified Nanoparticulate Carrier Constructs for Oral Mucosal Vaccine Delivery. Curr Drug Deliv. 2014 Jul 9. [Epub ahead of print].

15. Banajeh SM, Ashoor O, Al-Magramy AS. Childhood very severe pneumonia and meningitisrelated hospitalization and death in Yemen, before and after introduction of H. influenzae type b (Hib) vaccine. East Mediterr Health J. 2014  Jul 8;20(7):431-41.

16. Banaszkiewicz A, Klincewicz B, Łazowska-Przeorek I, Grzybowska-Chlebowczyk U, Kąkol P, Mytyk A, Kofla A, Radzikowski A. Influenza vaccination coverage in children with inflammatory bowel disease. Influenza Other Respir Viruses. 2014 Jul;8(4):431-5.

17. Basavaraj VH, Sampath G, Hegde NR, Mohan VK, Ella KM. Evaluation of safety and immunogenicity of HNVAC, an MDCK-based H1N1 pandemic influenza vaccine, in Phase I single centre and Phase II/III multi-centre, double-blind, randomized, placebo-controlled, parallel assignment studies. Vaccine. 2014 Jul 31;32(35):4592-7.

18. Beran J, Xie F, Zent O. Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety. Vaccine. 2014 Jul 23;32(34):4275-80.

19. Betancourt-Cravioto M, Kuri-Morales P, González-Roldán JF, Tapia-Conyer R; Mexican Dengue Expert Group. Introducing a dengue vaccine to Mexico: development  of a system for evidence-based public policy recommendations. PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3009.

20. Betsch C, Wicker S. Personal attitudes and misconceptions, not official recommendations guide occupational physicians' vaccination decisions. Vaccine. 2014 Jul 31;32(35):4478-84.

21. Bhatta MP, Phillips L. Human Papillomavirus Vaccine Awareness, Uptake, and Parental and Health Care Provider Communication Among 11- to 18-Year-Old Adolescents in a Rural Appalachian Ohio County in the United States. J Rural Health. 2014 Jul 8. [Epub ahead of print].

22. Bhuiyan TR, Choudhury FK, Khanam F, Saha A, Sayeed MA, Salma U, Qadri F, Lundgren A, Svennerholm AM, Sack DA. Response on letter by Arya et al.: "evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh." Vaccine. 2014 Jul 7;32(32):4014.

23. Block J. Smallpox vaccines and eczema. Biosecur Bioterror. 2014 Jul-Aug; 12(4):218.

24. Blyth CC, Richmond PC, Jacoby P, Thornton P, Regan A, Robins C, Kelly H, Smith DW, Effler PV. The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children. Vaccine. 2014 Jul 7; 32(32):4075-81.

25. Bonduelle O, Carrat F, Luyt CE, Leport C, Mosnier A, Benhabiles N, Krivine A, Rozenberg F, Yahia N, Samri A, Rousset D, van der Werf S, Autran B, Combadiere B. Characterization of pandemic influenza immune memory signature after vaccination  or infection. J Clin Invest. 2014 Jul 1; 124(7):3129-36.

26. Bordbar B, Tuikue Ndam N, Renard E, Jafari-Guemouri S, Tavul L, Jennison C, Gnidehou S, Tahar R, Gamboa D, Bendezu J, Menard D, Barry AE, Deloron P, Sabbagh  A. Genetic diversity of VAR2CSA ID1 DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria. Infect Genet Evol. 2014 Jul; 25:81-92.

27. Brito LA, O'Hagan DT. Designing and building the next generation of improved  vaccine adjuvants. J Control Release. 2014 Jul 3. [Epub ahead of print].

28. Brown ST, Schreiber B, Cakouros BE, Wateska AR, Dicko HM, Connor DL, Jaillard P, Mvundura M, Norman BA, Levin C, Rajgopal J, Avella M, Lebrun C, Claypool E, Paul P, Lee BY. The benefits of redesigning Benin's vaccine supply chain. Vaccine. 2014 Jul 7; 32(32):4097-103.

29. Buchanan R, Beckett RD. Assessment of vaccination-related information for consumers available on Facebook(®). Health Info Libr J. 2014 Jul 6. [Epub ahead of print].

30. Buttery JP, Kirkwood CD. What can rotavirus vaccines teach us about rotavirus? Lancet Infect Dis. 2014 Jul 28. [Epub ahead of print].

31. Buttery JP, Standish J, Bines JE. Intussusception and rotavirus vaccines: consensus on benefits outweighing recognized risk. Pediatr Infect Dis J. 2014 Jul; 33(7):772-3.

32. Byington CL. Vaccines: can transparency increase confidence and reduce hesitancy? Pediatrics. 2014 Aug;134(2):377-9.

33. Bödeker B, Walter D, Reiter S, Wichmann O. Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany. Vaccine. 2014 Jul 16; 32(33):4131-9.

34. Campbell LJ, Li Q, Li Y. Healthcare Worker Influenza Vaccination in Oregon Nursing Homes: Correlates of Facility Characteristics. J Am Med Dir Assoc. 2014 Jul 20. [Epub ahead of print].

35. Campi-Azevedo AC, de Almeida Estevam P, Coelho-Dos-Reis JG, Peruhype-Magalhães V, Villela Rezende G, Quaresma PF, Maia Mde L, Farias RH, Camacho LA, Freire Mda S, Galler R, Yamamura AM, Almeida LF, Lima SM, Nogueira RM, Silva Sá GR, Hokama DA, de Carvalho R, Freire RA, Filho EP, Leal Mda L, Homma A, Teixeira-Carvalho A, Martins RM, Martins-Filho OA. Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline. BMC  Infect Dis. 2014 Jul 15;14(1):391.

36. Cao RG, Suarez NM, Obermoser G, Lopez SM, Flano E, Mertz SE, Albrecht RA, García-Sastre A, Mejias A, Xu H, Qin H, Blankenship D, Palucka K, Pascual V, Ramilo O. Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children. J Infect Dis. 2014 Jul 15;210(2):224-33.

37. Carlton CA, Potter RC, Vranesich PA, Swanson RG. Assessing the Ability of an  Immunization Information System to Prevent Overimmunization of Pediatric Influenza Vaccines. J Public Health Manag Pract. 2014 Jul 31. [Epub ahead of print].

38. Cashman P, Moberley S, Dalton C, Stephenson J, Elvidge E, Butler M, Durrheim  DN. Vaxtracker: Active on-line surveillance for adverse events following inactivated influenza vaccine in children. Vaccine. 2014 Jul 28. [Epub ahead of print].

39. Cassone A. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG. 2014 Jul 23. [Epub ahead of print].

40. Cates JR, Diehl SJ, Crandell JL, Coyne-Beasley T. Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys. Vaccine. 2014 Jul 16;32(33):4171-8.

41. Chapman AL. Risk of stroke following herpes zoster: implications for national recommendations on timing of antiviral therapy for zoster and on zoster vaccination. Clin Infect Dis. 2014 Jul 17. [Epub ahead of print].

42. Chaudhury S, Reifman J, Wallqvist A. Simulation of B Cell Affinity Maturation Explains Enhanced Antibody Cross-Reactivity Induced by the Polyvalent Malaria Vaccine AMA1. J Immunol. 2014 Jul 30. [Epub ahead of print].

43. Cherry JD, Paddock CD. Pathogenesis and histopathology of pertussis: implications for immunization. Expert Rev Vaccines. 2014 Jul 4:1-9. [Epub ahead of print].

44. Chesson H, Markowitz L. The cost-effectiveness of HPV vaccine catch-up programs for women. J Infect Dis. 2014 Jul 23. pii: jiu414. [Epub ahead of print].

45. Chiu SS, Ho PL, Khong PL, Ooi C, So LY, Wong WH, Chan EL. Population-based incidence of community-acquired pneumonia hospitalization in Hong Kong children younger than 5 years before universal conjugate pneumococcal immunization. J Microbiol Immunol Infect. 2014 Jul 25. 1182(14)00104-2. [Epub ahead of print].

46. Christodoulides M. Neisseria proteomics for antigen discovery and vaccine development. Expert Rev Proteomics. 2014 Jul 12:1-19. [Epub ahead of print].

47. Chua BY, Brown LE, Jackson DC. Considerations for the rapid deployment of vaccines against H7N9 influenza. Expert Rev Vaccines. 2014 Jul 12:1-11. [Epub ahead of print].

48. Clarke CE, Dixon GN, Holton A, McKeever BW. Including "Evidentiary Balance" in News Media Coverage of Vaccine Risk. Health Commun. 2014 Jul 10:1-12. [Epub ahead of print].

49. Clayton JL, Potter RC, Wells EV, Carlton CA, Boulton ML. Influenza vaccination of Michigan children by provider type, 2010-2011. Am J Prev Med. 2014 Jul;47(1):46-52.

50. Cleary BJ, Rice Ú, Eogan M, Metwally N, McAuliffe F. 2009 A/H1N1 influenza vaccination in pregnancy: uptake and pregnancy outcomes - a historical cohort study. Eur J Obstet Gynecol Reprod Biol. 2014 Jul;178:163-8.

51. Cohen JI, Ali MA, Bayat A, Steinberg SP, Park H, Gershon AA, Burbelo PD. Detection of Antibodies to Varicella-Zoster Virus in Recipients of the Varicella  Vaccine using a Luciferase Immunoprecipitation System Assay. Clin Vaccine Immunol. 2014 Jul 2. [Epub ahead of print].

52. Cruze AR, Zhang G, Thomas L, Alonso J, Sandoval L. Frequency and erroneous usage of temporary medical exemptions and knowledge of immunization guidelines among some Miami-Dade County Florida providers. Vaccine. 2014 Jul 31;32(35):4500-4.

53. Darvishian M, Gefenaite G, Turner RM, Pechlivanoglou P, Van der Hoek W, Van den Heuvel ER, Hak E. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community dwelling elderly. J Clin Epidemiol. 2014 Jul;67(7):734-44.

54. Dawood FS, Prapasiri P, Areerat P, Ruayajin A, Chittaganpitch M, Muangchana C, Baggett HC, Olsen SJ. Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥ 50 years. Influenza Other Respir Viruses. 2014 Jul;8(4):463-8.

55. de Barros JM, Scherer T, Charalampopoulos D, Khutoryanskiy VV, Edwards AD. A laminated polymer film formulation for enteric delivery of live vaccine and probiotic bacteria. J Pharm Sci. 2014 Jul;103(7):2022-32.

56. De Gregorio E, Rappuoli R. From empiricism to rational design: a personal perspective of the evolution of vaccine development. Nat Rev Immunol. 2014 Jul;14(7):505-14.

57. Debbink K, Lindesmith LC, Donaldson EF, Swanstrom J, Baric RS. Chimeric GII.4 Norovirus Virus-Like-Particle-Based Vaccines Induce Broadly Blocking Immune Responses. J Virol. 2014 Jul 1; 88(13):7256-66.

58. Del Giudice G, Rappuoli R. Inactivated and Adjuvanted Influenza Vaccines. Curr Top Microbiol Immunol. 2014 Jul 20. [Epub ahead of print].

59. Derwand R. Annual World Vaccine Congress 2014: A re-evaluation of the value proposition for increasing vaccine thermostability. Hum Vaccin Immunother. 2014 Jul 7; 10(10). [Epub ahead of print].

60. Desai SN, Kamat D. Closing the Global Immunization Gap: Delivery of Lifesaving Vaccines Through Innovation and Technology. Pediatr Rev. 2014 Jul; 35(7):e32-e40. Review.

61. Deshpande BR, Rao SR, Jentes ES, Hills SL, Fischer M, Gershman MD, Brunette GW, Ryan ET, LaRocque RC; the Global TravEpiNet Consortium. Use of Japanese Encephalitis Vaccine in US Travel Medicine Practices in Global TravEpiNet. Am J Trop Med Hyg. 2014 Jul 28. pii: 14-0062. [Epub ahead of print].

62. Didierlaurent AM, Collignon C, Bourguignon P, Wouters S, Fierens K, Fochesato M, Dendouga N, Langlet C, Malissen B, Lambrecht BN, Garçon N, Van Mechelen M, Morel S. Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells. J Immunol. 2014 Aug 15; 193(4):1920-30.

63. Dodds WJ. Important features of modified live virus vaccines - A comment. Can Vet J. 2014 Jul;55(7):609.

64. Doerr HW, Berger A. Vaccination against infectious diseases: What is promising? Med Microbiol Immunol. 2014 Jul 27. [Epub ahead of print].

65. Dollin J. Optimizing pediatric clinical care and advocacy in an online era: Report of the Canadian Paediatric Society Infectious Diseases and Immunization Committee. Can Fam Physician. 2014 Jul; 60(7):625-630. Review.

66. Dombkowski KJ, Costello LE, Harrington LB, Dong S, Kolasa M, Clark SJ. Age-specific strategies for immunization reminders and recalls: a registry-based  randomized trial. Am J Prev Med. 2014 Jul;47(1):1-8.

67. Dore RA, Stone ER, Buchanan CM. A social values analysis of parental decision making. J Psychol. 2014 Jul-Aug;148(4):477-504.

68. Dormitzer PR. Rapid Production of Synthetic Influenza Vaccines. Curr Top Microbiol Immunol. 2014 Jul 5. [Epub ahead of print].

69. Dotres CP, Puga R, Ricardo Y, Broño CR, Paredes B, Echemendía V, Rosell S, González N, García-Rivera D, Valdés Y; Laboratory-Pneumococci Group; Havana-Pneumococci Group, Goldblatt D, Vérez-Bencomo V. Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial. Vaccine. 2014 Jul 25. [Epub ahead of print].

70. Downs-Canner S, Bartlett DL. Regional delivery of oncolytic vaccinia virus: it's time for clinical trials. Ann Surg Oncol. 2014 Jul;21(7):2127-8.

71. Durán-Lobato M, Carrillo-Conde B, Khairandish Y, Peppas NA. Surface-Modified  P(HEMA-co-MAA) Nanogel Carriers for Oral Vaccine Delivery: Design, Characterization, and In Vitro Targeting Evaluation. Biomacromolecules. 2014 Jul 14;15(7):2725-34.

72. Eichner M, Schwehm M, Hain J, Uphoff H, Salzberger B, Knuf M, Schmidt-Ott R.  4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany. BMC Infect Dis. 2014 Jul 3; 14:365.  

73. Esposito S, Corona F, Barzon L, Cuoco F, Squarzon L, Marcati G, Torcoletti M, Gambino M, Palù G, Principi N. Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis. Expert Rev Vaccines. 2014 Jul 28:1-7. [Epub ahead of print].

74. Even MP, Young K, Winter G, Hook S, Engert J. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery. Eur J Pharm Biopharm. 2014 Jul; 87(2):338-46.

75. Fehervari Z. Modulating vaccine efficiency. Nat Immunol. 2014 Jul 21;15(8):706.

76. Fell D, Platt R, Lanes A, Wilson K, Kaufman J, Basso O, Buckeridge D. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG. 2014 Jul 10.[Epub ahead of print].

77. Findlow J, Findlow H, Frankland S, Holland A, Holme D, Newton E, Southern J,  Waight P, Kaczmarski E, Miller E, Borrow R. Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine. J Occup Med Toxicol. 2014 Jul 16;9:26.

78. Fitchett JR, Arnott ND. Influenza vaccination uptake among people aged over 85 years: an audit of primary care practice in the UK. JRSM Open. 2014 Jun 9; 5(7):2054270414531122.

79. Fox AT, Swan KE, Perkin M, du Toit G, Lack G. The changing pattern of measles, mumps and rubella vaccine uptake in egg-allergic children. Clin Exp Allergy. 2014 Jul;44(7):999-1002.

80. Frey SE, Reyes MR, Reynales H, Bermal NN, Nicolay U, Narasimhan V, Forleo-Neto E, Arora AK. Comparison of the safety and immunogenicity of an MF59(®)-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects. Vaccine. 2014 Jul 18. [Epub ahead of print].

81. Galen JE, Curtiss R 3rd. The delicate balance in genetically engineering live vaccines. Vaccine. 2014 Jul 31;32(35):4376-4385.

82. Galson JD, Pollard AJ, Trück J, Kelly DF. Studying the antibody repertoire after vaccination: practical applications. Trends Immunol. 2014 Jul;35(7):319-331.

83. Gaudelus J, Cohen R, Martinot A, Stahl JP, Lery T, Le Danvic M, Denis F. [HPV vaccination is still difficult to implement]. Med Mal Infect. 2014 Jul; 44(7):289-91.

84. Good MF. The Ability to Inoculate Purified Malaria Sporozoites Will Accelerate Vaccine and Drug Discovery. Am J Trop Med Hyg. 2014 Jul 28. [Epub ahead of print].

85. Goodswen SJ, Kennedy PJ, Ellis JT. Discovering a vaccine against neosporosis  using computers: is it feasible? Trends Parasitol. 2014 Aug; 30(8):401-411.

86. Guiso N, Hegerle N. Other Bordetellas, lessons for and from pertussis vaccines. Expert Rev Vaccines. 2014 Jul 18:1-9. [Epub ahead of print].

87. Guiso N. Pertussis vaccination and whooping cough: and now what? Expert Rev Vaccines. 2014 Jul 14:1-3. [Epub ahead of print].

88. Haer-Wigman L, Ait Soussan A, Ligthart P, de Haas M, van der Schoot CE. Molecular analysis of immunized Jr(a-) or Lan- patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a-) and Lan- phenotypes. Transfusion. 2014 Jul; 54(7):1836-46.

89. Halbroth BR, Heil A, Distler E, Dass M, Wagner EM, Plachter B, Probst HC, Strand D, Hartwig UF, Karner A, Aichinger G, Kistner O, Landfester K, Herr W. Superior In Vitro Stimulation of Human CD8+ T-Cells by Whole Virus versus Split Virus Influenza Vaccines. PLoS One. 2014 Jul 29; 9(7):e103392.

90. Hamidi A, Boog C, Jadhav S, Kreeftenberg H. Lessons learned during the development and transfer of technology related to a new Hib conjugate vaccine to  emerging vaccine manufacturers. Vaccine. 2014 Jul 16;32(33):4124-4130.

91. Han SB, Hwang JM, Kim JS, Yang HK. Optic neuritis following Varicella zoster vaccination: Report of two cases. Vaccine. 2014 Jul 18. [Epub ahead of print].

92. Harboe ZB, Dalby T, Weinberger D, Benfield T, Mølbak K, Slotved HC, Suppli CH, Konradsen HB, Branth PV. Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality. Clin Infect Dis. 2014 Jul 16. [Epub ahead of print].

93. Harper DM. Conclusions About the Quadrivalent Human Papillomavirus Vaccine Efficacy Based on Alternate Dosing Schedules and Less Than Three Dose Immunogenicity is Inappropriate. J Infect Dis. 2014 Jul 15;210(2):330-1.

94. Harper DM, Else BM, Bartley MJ, Arey AM, Barnett AL, Rosemergey BE, Paynter  CA, Verdenius I, Harper SM, Harris GD, Groner JA, Malnar GJ, Wall J, Bonham AJ. In a Safety Net Population HPV4 Vaccine Adherence Worsens as BMI Increases. PLoS One. 2014 Jul 30;9(7):e103172.

95. Harriman K, Winter K. Pertussis vaccine uptake during pregnancy: We need to  do better in the U.S. Prev Med. 2014 Jul 15. [Epub ahead of print].

96. Harrison C. Vaccines: Nanorings boost vaccine adjuvant effects. Nat Rev Drug Discov. 2014 Jul 1; 13(7):496.

97. Havers F, Fry A, Peacock G, Finelli L. Influenza vaccination and treatment in children with neurologic disorders. Ther Adv Vaccines. 2014 Jul;2(4):95-105.

98. Hedden MA, Kuehl PG, Liu Y. Economic analysis of a herpes zoster vaccination program in 19 affiliated supermarket pharmacies. J Am Pharm Assoc (2003). 2014 Jul 1;54(4):390-6.

99. Hernon M, Sloan H, Thompson R, De Cruze B, Sanders C, Creighton SM. Should we vaccinate against and test for human papillomavirus infection in adolescent girls and women with a neovagina? J Fam Plann Reprod Health Care. 2014 Jul; 40(3):161-4.

100. Hobbs JL, Buxton JA. Influenza immunization in Canada's low-income population. BMC Public Health. 2014 Jul 21;14:740.

101. Hotez PJ, Bottazzi ME, Tseng CT, Zhan B, Lustigman S, Du L, Jiang S. Calling for rapid development of a safe and effective MERS vaccine. Microbes Infect. 2014 Jul;16(7):529-31.

102. Hou Z, Jie Chang, Yue D, Fang H, Meng Q, Zhang Y. Determinants of willingness to pay for self-paid vaccines in China. Vaccine. 2014 Jul 31;32(35):4471-7.

103. Hu S, Shi Q, Chen CI, Caldwell R, Wang B, Du L, He J, Roberts CS. Estimated  public health impact of nationwide vaccination of infants with 7-valent pneumococcal conjugate vaccine (PCV7) in China. Int J Infect Dis. 2014 Jul 4; 26C:116-122. [Epub ahead of print].

104. Huang LM, Chiu NC, Yeh SJ, Bhusal C, Arora AK. Immunogenicity and safety of  a single dose of a CRM-conjugated meningococcal ACWY vaccine in children and adolescents aged 2-18 years in Taiwan: Results of an open label study. Vaccine. 2014 Jul 27. [Epub ahead of print].

105. Huang YL, Moon J, Segal JB. A Comparison of Active Adverse Event Surveillance Systems Worldwide. Drug Saf. 2014 Jul 15. [Epub ahead of print].

106. Huppertz H, Borte M, Schuster V, Giaquinto C, Vesikari T. Report of the Third European Expert Meeting on Rotavirus Vaccination: Progress in rotavirus universal mass vaccination in Europe. Vaccine. 2014 Jul 23; 32(34):4243-8.

107. Idoko OT, Okolo SN, Plikaytis B, Akinsola A, Viviani S, Borrow R, Carlone G, Findlow H, Elie C, Kulkarni PS, Preziosi MP, Ota M, Kampmann B. The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines. Vaccine. 2014 Jul 16; 32(33):4220-7.

108. Iroh Tam PY, Madoff LC, Coombes B, Pelton SI. Invasive pneumococcal disease  after implementation of 13-valent conjugate vaccine. Pediatrics. 2014 Aug; 134(2):210-7.

109.  Jackson KJ, Liu Y, Roskin KM, Glanville J, Hoh RA, Seo K, Marshall EL, Gurley TC, Moody MA, Haynes BF, Walter EB, Liao HX, Albrecht RA, García-Sastre A, Chaparro-Riggers J, Rajpal A, Pons J, Simen BB, Hanczaruk B, Dekker CL, Laserson  J, Koller D, Davis MM, Fire AZ, Boyd SD. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host  Microbe. 2014 Jul 9;16(1):105-14.

110. Jahnmatz M, Ljungman M, Netterlid E, Jenmalm MC, Nilsson L, Thorstensson R.  Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine. Clin Vaccine Immunol. 2014 Jul 9. [Epub ahead of print].

111. Jegaskanda S, Reading PC, Kent SJ. Influenza-Specific Antibody-Dependent Cellular Cytotoxicity: Toward a Universal Influenza Vaccine. J Immunol. 2014 Jul  15;193(2):469-475.

112. Jenness E, Walker S. Advantages of single-use technology for vaccine fill-finish operations. PDA J Pharm Sci Technol. 2014 Jul-Aug;68(4):381-3.

113. Jiménez-García R, Hernandez-Barrera V, Rodríguez-Rieiro C, Carrasco Garrido  P, López de Andres A, Jimenez-Trujillo I, Esteban-Vasallo MD, Domínguez-Berjón MF, de Miguel-Diez J, Astray-Mochales J. Comparison of self-report influenza vaccination coverage with data from a population based computerized vaccination registry and factors associated with discordance. Vaccine. 2014 Jul 31; 32(35):4386-92.

114. Jin H, Subbarao K. Live Attenuated Influenza Vaccine. Curr Top Microbiol Immunol. 2014 Jul 25. [Epub ahead of print].

115. Johansen K. The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation. Dev Med Child Neurol. 2014 Jul 23. [Epub ahead of print].

116. John J, Giri S, Karthikeyan AS, Iturriza-Gomara M, Muliyil J, Abraham A, Grassly NC, Kang G. Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial. Lancet. 2014 Jul 10. [Epub ahead of print].

117. Jones M, Buttenheim A. Potential Effects of California's New Vaccine Exemption Law on the Prevalence and Clustering of Exemptions. Am J Public Health. 2014 Jul 17:e1-e4. [Epub ahead of print].

118. Juergens C, Patterson S, Trammel J, Greenberg D, Givon-Lavi N, Cooper D, Gurtman A, Gruber WC, Scott DA, Dagan R. Correlation of Functional and Binding Antibody Responses Elicited by 13-valent and 7-valent Pneumococcal Conjugate Vaccine and Association With Nasopharyngeal Colonization: Post Hoc Analysis of a  Randomized Double-blind Trial. Clin Vaccine Immunol. 2014 Jul 2. [Epub ahead of print].

119. Kabir S. The Compositions and Protective Efficacies of the Oral Killed Cholera Vaccines: A Critical Analysis. Clin Vaccine Immunol. 2014 Jul 23. [Epub ahead of print].

120. Kang HS, De Gagne JC, Kim JH. Attitudes, Intentions, and Barriers Toward Influenza Vaccination Among Korean Pregnant Women. Health Care Women Int. 2014 Jul 25:0. [Epub ahead of print].

121. Kanungo S, Sen B, Ramamurthy T, Sur D, Manna B, Pazhani GP, Chowdhury G, Jhunjhunwala P, Nandy RK, Koley H, Bhattacharya MK, Gupta S, Goel G, Dey B, M T,  Nair GB, Ghosh A, Mahalanabis D. Safety and Immunogenicity of a Live Oral Recombinant Cholera Vaccine VA1.4: A Randomized, Placebo Controlled Trial in Healthy Adults in a Cholera Endemic Area in Kolkata, India. PLoS One. 2014 Jul 1;9(7):e99381.

122. Kartoglu U, Milstien J. Tools and approaches to ensure quality of vaccines throughout the cold chain. Expert Rev Vaccines. 2014 Jul; 13(7):843-54.

123. Keselman A, Smith CA, Hundal S. Library workers' personal beliefs about childhood vaccination and vaccination information provision. J Med Libr Assoc. 2014 Jul;102(3):205-10.

124. Khamesipour A. Therapeutic vaccines for leishmaniasis. Expert Opin Biol Ther. 2014 Jul 31:1-9. [Epub ahead of print].

125. Khatami A, Clutterbuck EA, Thompson AJ, McKenna JA, Pace D, Birks J, Snape MD, Pollard AJ. Evaluation of the Induction of Immune Memory following Infant Immunisation with Serogroup C Neisseria meningitidis Conjugate Vaccines - Exploratory Analyses within a Randomised Controlled Trial. PLoS One. 2014 Jul 14; 9(7):e101672.

126. Kilgus CD, Redmon GS. Enabling reimbursement to health departments for immunization services. J Public Health Manag Pract. 2014 Jul-Aug; 20(4):453-5.

127. Kim TH. Seasonal influenza and vaccine herd effect. Clin Exp Vaccine Res. 2014 Jul;3(2):128-32.

128. Kim Y, Lee H, Heo L, Seok C, Choe J. Structure of vaccinia virus A46, an inhibitor of TLR4 signaling pathway, shows the conformation of VIPER motif. Protein Sci. 2014 Jul;23(7):906-14.

129. Kinsey B. Vaccines against drugs of abuse: where are we now? Ther Adv Vaccines. 2014 Jul;2(4):106-17.

130. Klein SL, Pekosz A. Sex-based Biology and the Rational Design of Influenza Vaccination Strategies. J Infect Dis. 2014 Jul 15;209 Suppl 3:S114-9.

131. Knight JM, Zingales B, Bottazzi ME, Hotez P, Zhan B. Limited Antigenic Variation in the Trypanosoma cruzi candidate vaccine antigen TSA-1. Parasite Immunol. 2014 Jul 16. [Epub ahead of print].  

132. Kordeluk S, Orgad R, Kraus M, Puterman M, Kaplan DM, Novak L, Dagan R, Leibovitz E. Acute mastoiditis in children under 15 years of age in Southern Israel following the introduction of pneumococcal conjugate vaccines: A 4-year retrospective study (2009-2012). Int J Pediatr Otorhinolaryngol. 2014 Jul 11. [Epub ahead of print].

133. Kosten TR, Domingo CB, Shorter D, Orson F, Green C, Somoza E, Sekerka R, Levin FR, Mariani JJ, Stitzer M, Tompkins DA, Rotrosen J, Thakkar V, Smoak B, Kampman K. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug Alcohol Depend. 2014 Jul 1;140:42-7.

134. Kotwal GJ, Fernando N, Zhou J, Valter K. Exploring the potential benefits of vaccinia virus complement control protein in controlling complement activation in pathogenesis of the central nervous system diseases. Mol Immunol. 2014 Jul 19. [Epub ahead of print].

135. Koul PA, Bali NK, Ali S, Ahmad SJ, Bhat MA, Mir H, Akram S, Khan UH. Poor uptake of influenza vaccination in pregnancy in northern India. Int J Gynaecol Obstet. 2014 Jul 17. [Epub ahead of print].

136. Krall P, Kubal A. Herpes Zoster Stromal Keratitis After Varicella Vaccine Booster in a Pediatric Patient. Cornea. 2014 Jul 24. [Epub ahead of print].

137. Kuehn BM. High rotavirus vaccination rates continue to pay off. JAMA. 2014 Jul 2;312(1):18.

138. Kuo PF, Yeh YT, Sheu SJ, Wang TF. Factors associated with future commitment  and past history of human papilloma virus vaccination among female college students in northern Taiwan. J Gynecol Oncol. 2014 Jul;25(3):188-97.

139. Kříłová P, Musílek M, Vacková Z, Kozáková J, Claus H, Vogel U, Medini D. Predicted strain coverage of a new protein-based meningococcal vaccine in the Czech Republic. Epidemiol Mikrobiol Imunol. 2014 Summer; 63(2):103-106.

140. Ladhani SN, Cordery R, Mandal S, Christensen H, Campbell H, Borrow R, Ramsay M; the PHE VaPIBI Forum Members. Preventing secondary cases of invasive meningococcal capsular group B (MenB) disease using a recently-licensed, multi-component, protein-based vaccine (Bexsero(®)). J Infect. 2014 Jul 18. [Epub ahead of print].

141. Lalwani S, Chatterjee S, Chhatwal J, Simon A, Ravula S, Francois N, Mehta S, Strezova A, Borys D. Impact of age on booster responses to the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in children in India: a randomized, open-label study. Clin Vaccine Immunol. 2014 Jul 9. [Epub ahead of print].

142. Langley JM, Krahn M, Husereau D, Spika J, Fisman DN, Chit A, Van Exan R. Incorporating economic evaluation into immunization decision making in Canada: a  workshop. Expert Rev Vaccines. 2014 Jul 23:1-6. [Epub ahead of print].

143. Launay O, Boelle PY, Krivine A, Grenet D, Boussaud V, Rémus N, Corvol H, Chedevergne F, Hubert D, Sermet-Gaudelus I; Inserm MUCOFLU group. Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis. Vaccine. 2014 Jul 31;32(35):4515-21.

144. Laxminarayan R, Jamison DT, Krupnick AJ, Norheim OF. Valuing vaccines using  value of statistical life measures. Vaccine. 2014 Jul 18. [Epub ahead of print].

145. Le TH, Nguyen NT. Evolutionary dynamics of highly pathogenic avian influenza A/H5N1 HA clades and vaccine implementation in Vietnam. Clin Exp Vaccine Res. 2014 Jul;3(2):117-27.

146. Lessa R, Castillo M, Azevedo R, Azevedo F, Azevedo H. Neurological complications after H1N1 influenza vaccination: magnetic resonance imaging findings. Arq Neuropsiquiatr. 2014 Jul;72(7):496-9.

147. Levene I. Does topical local anaesthetic reduce pain from vaccinations in infants? Arch Dis Child. 2014 Jul 8. [Epub ahead of print].

148. Levin Y, Kochba E, Kenney R. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: Are all delivery methods the same? Vaccine. 2014 Jul 23; 32(34):4249-52.

149. Levy C, Varon E, Picard C, Béchet S, Martinot A, Bonacorsi S, Cohen R. Trends of Pneumococcal Meningitis in Children after Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in France. Pediatr Infect Dis J. 2014 Jul 16. [Epub ahead of print].

150. Lewthwaite P, Campion K, Blackburn B, Kemp E, Major D, Sarangi K. Healthcare workers' attitude towards influenza vaccination after the 2009 pandemic. Occup Med (Lond). 2014 Jul;64(5):348-51.

151. Li F, Cheng K, Antoline JF, Iyer MR, Matyas GR, Torres OB, Jalah R, Beck Z,  Alving CR, Parrish DA, Deschamps JR, Jacobson AE, Rice KC. Synthesis and immunological effects of heroin vaccines. Org Biomol Chem. 2014 Jul 4. [Epub ahead of print].

152. Liko J, Robison SG, Cieslak PR. Pertussis vaccine performance in an epidemic year-Oregon, 2012. Clin Infect Dis. 2014 Jul 15; 59(2):261-3.

153. Long SS. Immunization exemptions leave kindergarten entrants at higher risk  for vaccine-preventable diseases. J Pediatr. 2014 Jul; 165(1):1-3.

154. Loulergue P, Pulcini C, Massin S, Bernhard M, Fonteneau L, Levy-Brühl D, Guthmann JP, Launay O. Validity of self-reported vaccination status among French  healthcare students. Clin Microbiol Infect. 2014 Jul 7. [Epub ahead of print].

155. Low JG, Lee LS, Ooi EE, Ethirajulu K, Yeo P, Matter A, Connolly JE, Skibinski DA, Saudan P, Bachmann M, Hanson BJ, Lu Q, Maurer-Stroh S, Lim S, Novotny-Diermayr V. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase  I clinical trial in healthy Asian volunteers. Vaccine. 2014 Jul 18. [Epub ahead of print].

156: Lu PJ, O'Halloran A, Bryan L, Kennedy ED, Ding H, Graitcer SB, Santibanez TA, Meghani A, Singleton JA. Trends in racial/ethnic disparities in influenza vaccination coverage among adults during the 2007-08 through 2011-12 seasons. Am  J Infect Control. 2014 Jul; 42(7):763-9.

157. Luke CJ, Subbarao K. Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms. Expert Rev Vaccines. 2014 Jul;13(7):873-83.

158. Macintosh J, Luthy KE, Beckstrand RL, Eden LM, Orton J. Vaccination perceptions of school employees in a rural school district. Vaccine. 2014 Jul 10. [Epub ahead of print].

159. MacNeil A, Lee CW, Dietz V. Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveys. Vaccine. 2014 Jul 18. [Epub ahead of print].

160. Maiden MC, MacLennan JM. Fifteen years of protection by meningococcal C conjugate vaccines: lessons from disease surveillance. Clin Infect Dis. 2014 Jul  28. [Epub ahead of print].

161. Mandile MG, Esteban LE, Argüelles MH, Mistchenko A, Glikmann G, Castello AA. Surveillance of group A Rotavirus in Buenos Aires 2008-2011, long lasting circulation of G2P[4] strains possibly linked to massive monovalent vaccination in the region. J Clin Virol. 2014 Jul; 60(3):282-9.

162. Mathew S, Lendlein A, Wischke C. Characterization of protein-adjuvant coencapsulation in microparticles for vaccine delivery. Eur J Pharm Biopharm. 2014 Jul;87(2):403-7.

163. Mazza D, Petrovic K, Grech C, Harris N. HPV vaccination in women aged 27 to  45 years: What do general practitioners think? BMC Womens Health. 2014 Jul 30; 14(1):91. [Epub ahead of print].

164. McAllister SC, Schleiss MR. Prospects and perspectives for development of a  vaccine against herpes simplex virus infections. Expert Rev Vaccines. 2014 Jul 31:1-12. [Epub ahead of print].

165. McCarthy M. Severe vaccine complications are rare, review finds. BMJ. 2014 Jul 3;349:g4411.

166. McCarthy M. US falls short of target for vaccinating adolescents against HPV. BMJ. 2014 Jul 28;349:g4877.

167. McIntyre PB, Clark TA. Pertussis vaccine in pregnancy-first dose for every infant? Lancet. 2014 Jul 15. [Epub ahead of print].

168. McQuaid F, Snape MD, John TM, Kelly S, Robinson H, Houlden J, Voysey M, Toneatto D, Kitte C, Dull PM, Pollard AJ. Persistence of bactericidal antibodies  to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age. Pediatr Infect Dis J. 2014 Jul;33(7):760-6.

169. McRee AL, Gilkey MB, Dempsey AF. HPV Vaccine Hesitancy: Findings From a Statewide Survey of Health Care Providers. J Pediatr Health Care. 2014 Jul 10. [Epub ahead of print].

170. Meharry PM, Cusson RM, Stiller R, Vázquez M. Maternal influenza vaccination: evaluation of a patient-centered pamphlet designed to increase uptake in pregnancy. Matern Child Health J. 2014 Jul;18(5):1205-14.

171. Meseda CA, Kuhn J, Atukorale V, Campbell J, Weir JP. Glycosylated and Non-glycosylated Complement Control Protein of the Lister Strain of Vaccinia Virus. Clin Vaccine Immunol. 2014 Jul 16. [Epub ahead of print].

172. Messaoudi I, Pasala S, Grant K. Could moderate alcohol intake be recommended to improve vaccine responses? Expert Rev Vaccines. 2014 Jul;13(7):817-9.

173. Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States. BMC Public Health. 2014 Jul 15;14:718.

174. Mirsaeidi M, Schraufnagel DE. Pneumococcal vaccines: understanding centers for disease control and prevention recommendations. Ann Am Thorac Soc. 2014 Jul; 11(6):980-5.

175. Moriarty LF, Omer SB. Infants and the seasonal influenza vaccine: A global perspective on safety, effectiveness, and alternate forms of protection. Hum Vaccin Immunother. 2014 Jul 3; 10(9). [Epub ahead of print].

176. Mudur G. India to introduce rubella and rotavirus vaccines and inactivated polio vaccine. BMJ. 2014 Jul 25;349:g4844.

177. Mugitani A, Ito K, Irie S, Eto T, Ishibashi M, Ohfuji S, Fukushima W, Maeda  A, Hirota Y; the Fukuoka Pediatricians Group for Vaccine Efficacy. Immunogenicity of the Trivalent Inactivated Influenza Vaccine in Young Children Less Than 4 Years of Age: Focus on Age and Baseline Antibodies. Clin Vaccine Immunol. 2014 Jul 2. [Epub ahead of print].

178. Mukherjee S, Madhivanan P, Li T, Albatineh A, Srinivas V, Jaykrishna P, Arun A, Krupp K. Correlates of completing routine vaccination among children in Mysore, India. J Infect Public Health. 2014 Jul 14. [Epub ahead of print].

179. Murhekar MV, Ranjan P, Selvaraju S, Pandey A, Gore MM, Mehendale SM. Low coverage and acceptable effectiveness of single dose of Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2013. J Infect. 2014 Jul 1. [Epub ahead of print].

180. Na CH, Kim DJ, Kim MS, Kim JK, Shin BS. Successful treatment of molluscum contagiosum with intralesional immunotherapy by measles, mumps, and rubella vaccine: a report of two cases. Dermatol Ther. 2014 Jul 22. [Epub ahead of print].

181. Na CH, Choi H, Song SH, Kim MS, Shin BS. Two-year experience of using the measles, mumps and rubella vaccine as intralesional immunotherapy for warts. Clin Exp Dermatol. 2014 Jul; 39(5):583-9.

182. Nafziger AN, Pratt DS. Seasonal influenza vaccination and technologies. J Clin Pharmacol. 2014 Jul;54(7):719-31.

183. Nan X, Dahlstrom MF, Richards A, Rangarajan S. Influence of Evidence Type and Narrative Type on HPV Risk Perception and Intention to Obtain the HPV Vaccine. Health Commun. 2014 Jul 25:1-8. [Epub ahead of print].

184. Nguyen GT, Klusaritz HA, Cronholm PF. Achieving sustainable increases in childhood immunization rates. Fam Pract Manag. 2014 Jul-Aug;21(4):13-7.

185. Nitiyarom R, Wongpraparut C. Hydroa vacciniforme and solar urticaria. Dermatol Clin. 2014 Jul;32(3):345-53, viii.

186. Nofal A, Nofal E, Yosef A, Nofal H. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach. Int J Dermatol. 2014 Jul 29. [Epub ahead of print].

187. Nolwenn N, Bisceglia H, Rozières A, Goujon C, Boudet F, Laurent P, Vanbervliet B, Rodet K, Hennino A, Nicolas JF. Nine µg intradermal influenza vaccine and 15 µg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults. Hum Vaccin Immunother. 2014 Jul 3;10(9). [Epub ahead of print].

188. Nomura K, Rahman M. HPV vaccine uptake among Asian American girls aged 9-17 years during 2008-2010. Int J Gynaecol Obstet. 2014 Jul;126(1):91-2.

189. Normile D. Tropical diseases. Dengue vaccine trial poses public health quandary. Science. 2014 Jul 25;345(6195):367-8.

190. Nunes B, Machado A, Guiomar R, Pechirra P, Conde P, Cristovão P, Falcão I. Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups. Vaccine. 2014 Jul 31;32(35):4443-9.

191. Nunes JK, Woods C, Carter T, Raphael T, Morin MJ, Diallo D, Leboulleux D, Jain S, Loucq C, Kaslow DC, Birkett AJ. Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward. Vaccine. 2014 Jul 28. [Epub ahead of print].

192. Okade H, Funatsu T, Eto M, Furuya Y, Mizunaga S, Nomura N, Mitsuyama J, Yamagishi Y, Mikamo H. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period. J Infect Chemother. 2014 Jul;20(7):423-8.

193. Osier FH, Mackinnon MJ, Crosnier C, Fegan G, Kamuyu G, Wanaguru M, Ogada E,  McDade B, Rayner JC, Wright GJ, Marsh K. New antigens for a multicomponent blood-stage malaria vaccine. Sci Transl Med. 2014 Jul 30;6(247):247ra102.

194. Ovsyannikova IG, Pankratz VS, Larrabee BR, Jacobson RM, Poland GA. HLA genotypes and rubella vaccine immune response: Additional evidence. Vaccine. 2014 Jul 16;32(33):4206-13.

195. Pakakasama S, Wattanatitan S, Techasaensiri C, Yoksan S, Sirireung S, Hongeng S. Immunogenicity of a live-attenuated Japanese encephalitis vaccine in children and adolescents after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2014 Jul 21. [Epub ahead of print].

196. Pascoe AR, Fiatarone Singh MA, Edwards KM. The effects of exercise on vaccination responses: a review of chronic and acute exercise interventions in humans. Brain Behav Immun. 2014 Jul;39:33-41.

197. Pastor M, Esquisabel A, Marquínez I, Talavera A, Pedraz JL. Cellulose acetate phthalate microparticles containing Vibrio cholerae: steps toward an oral cholera vaccine. J Drug Target. 2014 Jul;22(6):478-87.

198. Pedersen GK, Höschler K, Oie Solbak SM, Bredholt G, Pathirana RD, Afsar A, Breakwell L, Nøstbakken JK, Raae AJ, Brokstad KA, Sjursen H, Zambon M, Cox RJ. Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination. Vaccine. 2014 Jul 31;32(35):4550-7.

199. Pellegrino P, Carnovale C, Perrone V, Pozzi M, Antoniazzi S, Radice S, Clementi E. Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies. Vaccine. 2014 Jul 5. [Epub ahead of print].

200. Pellegrino P, Clementi E, Radice S. Infections, vaccinations, drugs and interactions. Eur J Clin Pharmacol. 2014 Jul;70(7):891-2.

201. Periasamy M, Datta M, Kannapiran M, Ramanathan VD, Venkatesan P. Neonatal Bacilli Calmette-Guerin vaccination and environmental mycobacteria in sensitizing antimycobacterial activity of macrophages. Am J Med Sci. 2014 Jul;348(1):57-64.

202. Pettit MW, Dyer PD, Mitchell JC, Griffiths PC, Alexander B, Cattoz B, Heenan RK, King SM, Schweins R, Pullen F, Wicks SR, Richardson SC. Construction and physiochemical characterisation of a multi-composite, potential oral vaccine delivery system (VDS). Int J Pharm. 2014 Jul 1;468(1-2):264-71.

203. Pfleiderer M, Trouvin JH, Brasseur D, Gränstrom M, Shivji R, Mura M, Cavaleri M. Summary of knowledge gaps related to quality and efficacy of current  influenza vaccines. Vaccine. 2014 Jul 31;32(35):4586-91.

204. Plans-Rubio P. Is the current prevention strategy based on vaccination coverage and epidemiological surveillance sufficient to achieve measles and rubella elimination in Europe? Expert Rev Anti Infect Ther. 2014 Jul; 12(7):723-6.

205. Prosper O, Ruktanonchai N, Martcheva M. Optimal vaccination and bednet maintenance for the control of malaria in a region with naturally acquired immunity. J Theor Biol. 2014 Jul 21;353:142-56.

206. Prue G. Vaccinate boys as well as girls against HPV: it works, and it may be cost effective. BMJ. 2014 Jul 29;349:g4834.

207. Pírez MC, Algorta G, Chamorro F, Romero C, Varela A, Cedres A, Giachetto G,  Montano A. Changes in hospitalizations for pneumonia after universal vaccination  with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type  b conjugate vaccine in a Pediatric Referral Hospital in Uruguay. Pediatr Infect Dis J. 2014 Jul; 33(7):753-9.

208. Quinn HL, Kearney MC, Courtenay AJ, McCrudden MT, Donnelly RF. The role of microneedles for drug and vaccine delivery. Expert Opin Drug Deliv. 2014 Jul 14:1-12. [Epub ahead of print].

209. Raaska K, Neuvonen PJ. Infections and possible vaccine-drug interactions. Eur J Clin Pharmacol. 2014 Jul;70(7):889-90.

210. Radin JM, Hawksworth AW, Blair PJ, Faix DJ, Raman R, Russell KL, Gray GC. Dramatic Decline of Respiratory Illness Among US Military Recruits After the Renewed Use of Adenovirus Vaccines. Clin Infect Dis. 2014 Jul 2. [Epub ahead of print].

211. Rajao DS, Anderson TK, Gauger PC, Vincent AL. Pathogenesis and Vaccination of Influenza A Virus in Swine. Curr Top Microbiol Immunol. 2014 Jul 18. [Epub ahead of print].

212. Reynolds D. Religiosity and parental acceptance of human papillomavirus (HPV) vaccine in 9-18 year-old girls. J Christ Nurs. 2014 Jul-Sep; 31(3):172-7.

213. Reynolds DL, Vidor E. Fully liquid DTaP-IPV-Hib pediatric combination vaccine (Pediacel): a review of 18 years of clinical experience. Expert Rev Vaccines. 2014 Aug;13(8):943-68.

214. Rha B, Tate JE, Weintraub E, Haber P, Yen C, Patel M, Cortese MM, DeStefano  F, Parashar UD. Intussusception following rotavirus vaccination: an updated review of the available evidence. Expert Rev Vaccines. 2014 Jul 26:1-10. [Epub ahead of print].

215. Rice AD, Adams MM, Lindsey SF, Swetnam DM, Manning BR, Smith AJ, Burrage AM, Wallace G, MacNeill AL, Moyer RW. Protective properties of vaccinia virus-based vaccines: skin scarification promotes a nonspecific immune response that protects against orthopoxvirus disease. J Virol. 2014 Jul;88(14):7753-63.

216. Richardson A, Morris DE, Clarke SC. Vaccination in Southeast Asia-Reducing meningitis, sepsis and pneumonia with new and existing vaccines. Vaccine. 2014 Jul 16; 32(33):4119-4123.

 217. Rodrigues MM, Ersching J. Neglected tropical diseases, bioinformatics and vaccines. J Infect Dis. 2014 Jul 28. [Epub ahead of print].

218. Roué JM, Nowak E, Le Gal G, Lemaitre T, Oger E, Poulhazan E, Giroux JD, Garenne A, Gagneur A. Impact of rotavirus vaccine in premature infants. Clin Vaccine Immunol. 2014 Jul 30. [Epub ahead of print].

219. RTS,S Clinical Trials Partnership (2014). Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites. PLoS Med. 2014 Jul 29; 11(7):e1001685.

220. Rubin LG, Schaffner W. Clinical practice. Care of the asplenic patient. N Engl J Med. 2014 Jul 24; 371(4):349-56.

221. Sadarangani M, Scheifele DW, Halperin SA, Vaudry W, Le Saux N, Tsang R, Bettinger JA; for the investigators of the Canadian Immunization Monitoring Program, ACTive (IMPACT); for the investigators of the Canadian Immunization Monitoring Program ACTive IMPACT. The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012. Clin Infect Dis. 2014 Jul 28.  [Epub ahead of print].

222. Salgado-Pabón W, Schlievert PM. Models matter: the search for an effective Staphylococcus aureus vaccine. Nat Rev Microbiol. 2014 Aug;12(8):585-91.

223. Savulescu C, Jiménez-Jorge S, Delgado-Sanz C, de Mateo S, Pozo F, Casas I, Larrauri A; Spanish Influenza Surveillance System. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: Test-negative case-control studies using surveillance data, Spain, 2003-2011. Vaccine. 2014 Jul 31;32(35):4404-11.

224. Scheller NM, Pasternak B, Svanström H, Hviid A. Quadrivalent human papillomavirus vaccine and the risk of venous thromboembolism. JAMA. 2014 Jul; 312(2):187-8.

225. Sehgal K, Dhodapkar KM, Dhodapkar MV. Targeting human dendritic cells in situ to improve vaccines. Immunol Lett. 2014 Jul 26. [Epub ahead of print].

226. Seo YB, Choi WS, Lee J, Song JY, Cheong HJ, Kim WJ. Comparison of the Immunogenicity and Safety of the Conventional Subunit, MF59-Adjuvanted, and Intradermal Influenza Vaccines in the Elderly. Clin Vaccine Immunol. 2014 Jul;21(7):989-96.

227. Shoenfeld Y, Tomljenovic L. Authors' Reply: Human Papilloma Virus Vaccine and Primary Ovarian Failure. Am J Reprod Immunol. 2014 Jul 1. [Epub ahead of print].

228. Shono A, Kondo M. Parents' preferences for seasonal influenza vaccine for their children in Japan. Vaccine. 2014 Jul 22. [Epub ahead of print].

229. Sinha G. Sanofi's dengue vaccine first to complete phase 3. Nat Biotechnol.  2014 Jul 8;32(7):605-6.

230. Skountzou I, Compans RW. Skin Immunization with Influenza Vaccines. Curr Top Microbiol Immunol. 2014 Jul 20. [Epub ahead of print].

231. Song L, Liu G, Umlauf S, Liu X, Li H, Tian H, Reiserova L, Hou F, Bell R, Tussey L. A rationally designed form of the TLR5 agonist, flagellin, supports superior immunogenicity of Influenza B globular head vaccines. Vaccine. 2014 Jul  23;32(34):4317-23.

232. Soubeyrand B, Greenberg M, Tibayrenc M, Louis J, Dutel C, Simondon F, Saadatian-Elahi M. Vaccination: An evolutionary engine for pathogens? Conference  report. Infect Genet Evol. 2014 Jul 19. [Epub ahead of print].

233. Stanley M, O'Mahony C, Barton S. HPV vaccination. BMJ. 2014 Jul 29;349:g4783.

234. Sullivan SG, Chilver MB, Higgins G, Cheng AC, Stocks NP. Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network. Med J Aust. 2014 Jul 21;201(2):109-11.

235. Swamy GK, Wheeler SM. Neonatal pertussis, cocooning and maternal immunization. Expert Rev Vaccines. 2014 Jul 30:1-8. [Epub ahead of print].

236. Taddio A, Smart S, Sheedy M, Yoon EW, Vyas C, Parikh C, Pillai Riddell R, Shah V. Impact of prenatal education on maternal utilization of analgesic interventions at future infant vaccinations: a cluster randomized trial. Pain. 2014 Jul; 155(7):1288-92.

237. Tallant A, Porter CK, Putnam SD, Tribble DR, Hooper TI, Riddle MS. Relative  cost-effectiveness of a norovirus vaccine in the deployed military setting compared to a vaccine against Campylobacter sp., ETEC, and Shigella sp. Vaccine.  2014 Jul 30. [Epub ahead of print].

238. Tang DC. A trail blazed through DNA vaccine, noninvasive vaccine, and innate-adaptive immunity duo. Hum Vaccin Immunother. 2014 Jul 21; 10(8). [Epub ahead of print].

239. Tang MY, Shahab L, Robb KA, Gardner B. Are parents more willing to vaccinate their children than themselves? J Health Psychol. 2014 Jul 1. [Epub ahead of print].

240. Tashani M, Barasheed O, Azeem M, Alfelali M, Badahdah AM, Bokhary H, Almasri N, Alshehri J, Matbouly G, Kalantan N, Heron L, Ridda I, Haworth E, Asghar A, Rashid H, Booy R. Pneumococcal Vaccine Uptake Among Australian Hajj pilgrims in 2011-13. Infect Disord Drug Targets. 2014 Jul 13. [Epub ahead of print].

241. Tate JE, Parashar UD. Rotavirus Vaccines in Routine Use. Clin Infect Dis. 2014 Jul 21. [Epub ahead of print].

242. Tatsumi M, Nagaoka Y, Tsugawa T, Yoto Y, Hori T, Tsutsumi H. Longitudinal analysis of VP7 gene of group A human rotavirus G2P[4] strains circulating in the pre-vaccine era in Sapporo, Japan from 1991-2011. Microbiol Immunol. 2014 Jul 17. [Epub ahead of print].

243. Teng JE, Thomson DR, Lascher JS, Raymond M, Ivers LC. Using Mobile Health (mHealth) and Geospatial Mapping Technology in a Mass Campaign for Reactive Oral  Cholera Vaccination in Rural Haiti. PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3050.

244. Terada K, Itoh Y, Fujii A, Kitagawa S, Ogita S, Ouchi K. Varicella-zoster virus-specific, cell-mediated immunity with interferon-gamma release assay after  vaccination of college students with no or intermediate IgG antibody response. J  Med Virol. 2014 Jul 31. [Epub ahead of print].

245. Thomas RE, Lorenzetti DL. Interventions to increase influenza vaccination rates of those 60 years and older in the community. Cochrane Database Syst Rev. 2014 Jul 7; 7:CD005188.

246. Thommes EW, Chit A, Meier GC, Bauch CT. Examining Ontario's universal influenza immunization program with a multi-strain dynamic model. Vaccine. 2014 Jul 10. [Epub ahead of print].

247. Thompson KM. Polio endgame management: focusing on performance with or without inactivated poliovirus vaccine. Lancet. 2014 Jul 10. pii: S0140-6736(14)60983-1. [Epub ahead of print].

248. Tohme RA, François J, Wannemuehler K, Magloire R, Carolina Danovaro-Holliday M, Flannery B, Cavallaro KF, Fitter DL, Purcell N, Dismer A, Tappero JW, Vertefeuille JF, Hyde TB. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination. Trop Med Int Health. 2014 Jul 16. [Epub ahead of print].

249. Trobaugh DW, Ryman KD, Klimstra WB. Can understanding the virulence mechanisms of RNA viruses lead us to a vaccine against eastern equine encephalitis virus and other alphaviruses? Expert Rev Vaccines. 2014 Jul 30:1-3.  [Epub ahead of print].

250. Ubale RV, Gala RP, Zughaier SM, D'Souza MJ. Induction of Death Receptor CD95 and Co-stimulatory Molecules CD80 and CD86 by Meningococcal Capsular Polysaccharide-Loaded Vaccine Nanoparticles. AAPS J. 2014 Jul 1. [Epub ahead of print].

251. Umeh R, Oguche S, Oguonu T, Pitmang S, Shu E, Onyia JT, Daniyam CA, Shwe D,  Ahmad A, Jongert E, Catteau G, Lievens M, Ofori-Anyinam O, Leach A. Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: A randomized, double-blind, lot-to-lot consistency trial. Vaccine. 2014 Jul 28. [Epub ahead of print].

252. van Essen GA, Beran J, Devaster JM, Durand C, Duval X, Esen M, Falsey AR, Feldman G, Gervais P, Innis BL, Kovac M, Launay O, Leroux-Roels G, McElhaney JE,  McNeil S, Oujaa M, Richardus JH, Ruiz Palacios G, Osborne RH, Oostvogels L. Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines. Influenza Other Respir Viruses. 2014 Jul;8(4):452-62.

253. van Kessel DA, Hoffman TW, van Velzen-Blad H, Zanen P, Rijkers GT, Grutters  JC. Response to pneumococcal vaccination in mannose-binding lectin-deficient adults with recurrent respiratory tract infections. Clin Exp Immunol. 2014 Jul; 177(1):272-9.

254. Vanegas M, Bermúdez A, Guerrero YA, Cortes-Vecino JA, Curtidor H, Patarroyo  ME, Lozano JM. Protecting capacity against malaria of chemically defined tetramer forms based on the Plasmodium falciparum apical sushi protein as potential vaccine components. Biochem Biophys Res Commun. 2014 Jul 22. [Epub ahead of print].

255. Vargha D. Between East and West: polio vaccination across the Iron Curtain in Cold War Hungary. Bull Hist Med. 2014 Summer; 88(2):319-43.

256. Veljkovic V, Glisic S, Veljkovic N, Bojic T, Dietrich U, Perovic VR, Colombatti A. Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism. Vaccine. 2014 Jul 19. pii: S0264 410X(14)00933-5. [Epub ahead of print].

257. Wallace GS, Seward JF, Pallansch MA; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC. Interim CDC Guidance for Polio Vaccination for Travel to and from Countries Affected by Wild Poliovirus. MMWR Morb Mortal Wkly Rep. 2014 Jul 11; 63(27):591-4.

258. Wang FJ, Sun XJ, Wang FL, Jiang LF, Xu EP, Guo JF. An outbreak of adult measles by nosocomial transmission in a high vaccination coverage community. Int  J Infect Dis. 2014 Jul 4;26C:67-70. [Epub ahead  of print].

259. Wang H, Hu Y, Zhang G, Zheng J, Li L, An Z. Meta-analysis of vaccine effectiveness of mumps-containing vaccine under different immunization srategies  in China. Vaccine. 2014 Jul 5. [Epub ahead of print]

260. Watanaveeradej V, Gibbons RV, Simasathien S, Nisalak A, Jarman RG, Kerdpanich A, Tournay E, De La Barrerra R, Dessy F, Toussaint JF, Eckels KH, Thomas SJ, Innis BL. Safety and immunogenicity of a rederived, live-attenuated dengue virus vaccine in healthy adults living in Thailand: a randomized trial. Am J Trop Med Hyg. 2014 Jul 2; 91(1):119-28.

261. Weidemann F, Dehnert M, Koch J, Wichmann O, Höhle M. Modelling the epidemiological impact of rotavirus vaccination in Germany - A Bayesian approach. Vaccine. 2014 Jul 18. [Epub ahead of print].

262. Who. Polio vaccines: WHO position paper, January 2014 - Recommendations. Vaccine. 2014 Jul 16; 32(33):4117-8.

263. Wiboonchutikul S, Manosuthi W, Sangsajja C, Thientong V, Likanonsakul S, Srisopha S, Termvises P, Rujitip J, Loiusirirotchanakul S, Puthavathana P. Baseline immunity to diphtheria and immunologic response after booster vaccination with reduced diphtheria and tetanus toxoid vaccine in Thai health care workers. Am J Infect Control. 2014 Jul; 42(7):e81-3.

264. Wilder-Smith A. Dengue vaccines: dawning at last? Lancet. 2014 Jul 10. [Epub ahead of print].

265. Willyard C. Resurrecting the 'yuppie vaccine'. Nat Med. 2014 Jul 7;20(7):698-701.

266. Winstone AM, Stellitano L, Verity C, Andrews N, Miller E, Stowe J, Shneerson J. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol. 2014 Jul 10. [Epub ahead of print].

267. Wiwanitkit V. Role of nurse in giving detailed rabies vaccination advice is key. Nurs Stand. 2014 Jul 9;28(45):33.

268. Wiznitzer M. RE: Human papillomavirus vaccine and primary ovarian failure paper. Am J Reprod Immunol. 2014 Jul 2. [Epub ahead of print].

269. Wolff ER, Madlon-Kay DJ. Childhood vaccine beliefs reported by somali and non-somali parents. J Am Board Fam Med. 2014 Jul-Aug;27(4):458-64.

270. Woolpert T, Phillips CJ, Sevick C, Crum-Cianflone NF, Blair PJ, Faix D. Health-Related Behaviors and Effectiveness of Trivalent Inactivated versus Live Attenuated Influenza Vaccine in Preventing Influenza Like Illness among Young Adults. PLoS One. 2014 Jul 11;9(7):e102154.

271. Worzella SL, Hayney MS. Inflammatory chronic diseases: Preventable by vaccines? J Am Pharm Assoc (2003). 2014 Jul 1;54(4):446-8.

272. Xu Y, Yuen PW, Lam JK. Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives. Pharmaceutics. 2014 Jul 10;6(3):378-415.

273. Yamin D, Balicer RD, Galvani AP. Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel. Vaccine. 2014 Jul 16; 32(33):4198-205.

274. Yan D, Zhang Y, Zhu S, Chen N, Li X, Wang D, Ma X, Zhu H, Tong W, Xu W. Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in sichuan, china. Clin Vaccine Immunol. 2014 Jul; 21(7):1012-8.

275. Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to vaccination:  a critical review. Soc Sci Med. 2014 Jul; 112:1-11.

276. Yuen CY, Tarrant M. Determinants of uptake of influenza vaccination among pregnant women - A systematic review. Vaccine. 2014 Aug 6;32(36):4602-4613.

277. Yuk JM, Jo EK. Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis. Clin Exp Vaccine Res. 2014 Jul; 3(2):155-67.

278. Zedda L, Forleo-Neto E, Vertruyen A, Raes M, Marchant A, Jansen W, Clouting  H, Arora A, Beatty ME, Galli G, Del Giudice G, Castellino F. Dissecting the Immune-Response to MF59®-Adjuvanted and Non-Adjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age. Pediatr Infect Dis J. 2014 Jul 16. [Epub ahead of print].

279:.Zhang HF, Wu ZX, Tang M, Lai YC. Effects of behavioral response and vaccination policy on epidemic spreading - an approach based on evolutionary-game dynamics. Sci Rep. 2014 Jul 11; 4:5666.

 

 

[top]